What a rotten few days for health care stocks! You couldn't count the number of double-digit decliners on your fingers even if you had three hands. And these three health-care stocks were among the worst performers -- with each falling over 20%.

One of the week's big losers announced a disappointing clinical update for its lead drug. Another saw its stock drop because of that same disappointment. The third health-care stock in the negative 20% club had good news from a court decision, but bad news from a positive Food and Drug Administration decision benefiting a competitor carried a more significant impact.

Which three health-care stocks were really crushed by the market this week? Find out by watching the slideshow below.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.